I mean wasn't Vitrogro supposed to treat burns? It was supposed to do a lot of things. And now it has been whittled down to treating diabetic ulcers. There seems to be a lot of claims that have been brushed under the carpet.
Then there was a deal with invitrogen and TIS started supply to U.S. I mean it's been years and looking at announcements, the inconsistencies and current assets. I'm wondering what the hype is about TIS.
I?m trying to find a solid small biotech to invest in and have to admit ? TIS is not it.
TIS Price at posting:
64.7¢ Sentiment: Sell Disclosure: Not Held
